WHO ICTRP trial
The PPK research of Peginterferon a-2a therapy on HBV and HCV
ChiCTR-RO-13004320 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-RO-13004320 |
|---|---|
| Public title | The PPK research of Peginterferon a-2a therapy on HBV and HCV |
| Scientific title | The PPK research of Peginterferon a-2a therapy on HBV and HCV |
| Primary sponsor | 302th Hospital of PLA |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Relative factors research |
| Phase | I (Phase I study) |
| Conditions | Chronic Hepatitis B and Chronic Hepatitis C |
| Interventions | 1:Peginterferon a-2a |
| Registration date | Jul 12, 2013 |
| Target size | 1:300 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: